EFFICACY AND SAFETY ASSESSMENT OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO INHALED CORTICOSTEROIDS IN ADOLESCENT PATIENTS WITH SYMPTOMATIC ASTHMA

被引:0
|
作者
Hamelmann, E. [1 ]
Boner, A. [2 ]
Bernstein, J. [3 ]
Moroni-Zentgraf, P. [4 ]
Engel, M. [4 ]
Avis, M. [5 ]
Unseld, A. [6 ]
Vandewalker [7 ]
机构
[1] Ruhr Univ Bochum, Klin Kinder & Jugendmed, Bochum, Germany
[2] Univ Verona, Dept Pediat, I-37100 Verona, Italy
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[5] Boehringer Ingelheim Bv, Alkmaar, Netherlands
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Clin Applicat, Biberach, Germany
[7] Clin Res Ozarks, Columbia, MO USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
54
引用
收藏
页码:S55 / S55
页数:1
相关论文
共 50 条
  • [31] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IMPROVES PEF IN PARTICIPANTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA
    Moroni-Zentgraf, Petra
    Hamelmann, Eckard
    Vogelberg, Christian
    Bernstein, Jonathan A.
    Harper, Thomas, III
    Engel, Michael
    El Azzi, Georges
    Finnigan, Helen
    Szefler, Stanley J.
    RESPIROLOGY, 2017, 22 : 105 - 105
  • [32] Once-daily tiotropium Respimat® add-on therapy improves PEF in participants aged 6-17 years with symptomatic asthma
    Hamelmann, Eckard
    Vogelberg, Christian
    Bernstein, Jonathan A.
    Harper, Thomas, III
    Moroni-Zentgraf, Petra
    Engel, Michael
    El Azzi, Georges
    Finnigan, Helen
    Szefler, Stanley J.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] Once-daily Tiotropium Respimat® Add-on to at Least ICS Maintenance Therapy Reduces Airflow Obstruction in Patients with Symptomatic Asthma, Independent of Allergic Status
    Murphy, Kevin R.
    Pearlman, David S.
    Dahl, Ronald
    Paggiaro, Pierluigi
    Engel, Michael
    Moroni-Zentgraf, Petra
    Luehmann, Reinhold
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB6 - AB6
  • [34] Tiotropium Respimat® add-on therapy in children with symptomatic asthma
    Vogelberg, Christian
    Moroni-Zentgraf, Petra
    Leonaviciute-Klimantaviciene, Migle
    Sigmund, Ralf
    Hamelmann, Eckard
    Engel, Michael
    Szefler, Stanley
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [35] Once-daily Tiotropium Respimat® Add-on Therapy Has a Safety Profile Comparable with Placebo in Children and Adolescents
    Vandewalker, Mark L.
    Hamelmann, Eckard
    Engel, Michael
    El Azzi, Georges
    Moroni-Zentgraf, Petra
    Unseld, Anna
    Vogelberg, Christian
    Szefler, Stanley J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB94 - AB94
  • [36] One-Year Study on the Efficacy and Safety of Tiotropium Respimat as Adjunctive Therapy to inhaled Corticosteroids (ICS) in adolescent Patients with symptomatic Asthma
    Hamelmann, E.
    Boner, A.
    Bernstein, J.
    Moroni-Zentgraf, P.
    Engel, M.
    Avis, M.
    Unseld, A.
    Vandewalker, M.
    Beck, E.
    INTERNIST, 2015, 56 : 49 - 49
  • [37] Once-daily tiotropium Respimat add-on therapy improves lung function in children with moderate symptomatic asthma, independent of the degree of airflow obstruction
    Vogelberg, Christian
    Halpin, David
    Voelker, Birgit
    Engel, Michael
    Luehmann, Reinhold
    Hamelmann, Eckard
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [38] LATE-BREAKING ABSTRACT: Once-daily tiotropium Respimat® add-on therapy improves lung function in children with moderate symptomatic asthma
    Schmidt, Olaf
    Hamelmann, Eckard
    Vogelberg, Christian
    Laki, Istvan
    El Azzi, Georges
    Engel, Michael
    Moroni-Zentgraf, Petra
    Finnigan, Helen
    Vandewalker, Mark
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] Once-Daily Tiotropium Is Well Tolerated as Add-On to Standard Treatment for Patients With Symptomatic Asthma Despite Receiving Inhaled Corticosteroids and Long-Acting β2-Agonists
    Bernstein, Jonathan A.
    Kerstjens, Huib A. M.
    Moroni-Zentgraf, Petra
    Engel, Michael
    Schmidt, Hendrik
    Halpin, David M. G.
    CHEST, 2013, 144 (04)
  • [40] A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma
    Meltzer, Eli O.
    Berger, William E.
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (01) : 14 - 26